Synovial cell secretion of IL-2 in vitro, a limiting dilution analysis.

Clin Exp Rheumatol

Department of Medicine, University of Alberta, Edmonton, Canada.

Published: August 1991

Limiting dilution analysis (LDA) was used to analyze the defect of production of IL-2 by synovial fluid cells in rheumatoid arthritis (RA). LDA is a relatively simple means of separating T-cell function from the potential effects of accessory-cells, suppressor factors and adsorption. The number of precursor cells for interleukin-2 (IL-2) secretion was determined among peripheral blood cells (PBL) from healthy control individuals, and in PBL and synovial fluid (SF) mononuclear cells from patients with rheumatoid arthritis (RA). Although the frequency of such cells in the PBL of the controls and RA patients was similar, that of the SF was significantly lower (about one sixth). This difference could not be accounted for by an inability of the SF cells to proliferate in culture, by the presence of suppressor cells, by absorption of IL-2, or by a relative lack of accessory-cell function in the SF fraction. Culturing synovial cells without stimulant for three days resulted in a two- to three-fold increase in the apparent frequency of secreting cells, but the same proportional increase followed similar manipulation of peripheral blood cells. Pre-incubation of normal lymphocytes in RA synovial fluid did not result in suppression of their ability to secrete IL-2. We conclude that the poor secretion of IL-2 after mitogen stimulation of SF cells is an intrinsic property of the T-cell, and not due to the presence of other factors. There was no evidence that this defect was selectively reversible by "resting" the cells prior to culture.

Download full-text PDF

Source

Publication Analysis

Top Keywords

synovial fluid
12
cells
12
secretion il-2
8
limiting dilution
8
dilution analysis
8
rheumatoid arthritis
8
peripheral blood
8
blood cells
8
cells pbl
8
il-2
6

Similar Publications

Dimethyl Fumarate attenuates synovial inflammation, reduces nociception, and inhibits the development of post-traumatic osteoarthritis.

Biomed Pharmacother

January 2025

Joseph Maxwell Cleland Atlanta VA Medical Center, Decatur, GA 30033, USA; Department of Orthopaedics, Emory Musculoskeletal Institute, Emory University, Atlanta, GA 30329, USA. Electronic address:

There is currently no cure or disease-modifying treatment for post-traumatic osteoarthritis (PTOA). This study aims to assess the efficacy of dimethyl fumarate (DMF), a US-FDA approved drug for multiple sclerosis, as a treatment for PTOA. PTOA was induced in male Lewis rats by medial meniscal transection (MMT) surgery, and DMF was intra-articularly administered once, one week following surgery.

View Article and Find Full Text PDF

Introduction: Intra-articular injections, commonly used in osteoarthritis treatment, are debated due to their potential link to septic arthritis, though its incidence remains low. Lidocaine, used as a "carrier" for therapeutic substances like hyaluronan or triamcinolone, has pain-relieving and antimicrobial properties. This study investigates the concentration-dependent antimicrobial effects of lidocaine in combination with hyaluronan and triamcinolone in both standard and synovial fluid cultures.

View Article and Find Full Text PDF

A Rare Case of Elbow Synovial Cyst with Radial Nerve Compression.

Diagnostics (Basel)

January 2025

Department of Physical Medicine and Rehabilitation, Wan Fang Hospital, Taipei Medical University, Taipei 116, Taiwan.

Elbow synovial cysts are rare and can mimic more frequently encountered disorders such as lateral epicondylitis, presenting diagnostic challenges. This report describes a woman in her mid-40s with persistent pain and weakness in her right forearm due to a synovial cyst compressing the radial nerve at the Arcade of Frohse. Despite initial suspicions of lateral epicondylitis, deeper investigation using sonography confirmed the presence of a compressive synovial cyst.

View Article and Find Full Text PDF

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by inflammation leading to joint damage and systemic complications. Angiogenesis promotes inflammation and contributes to RA progression. This study evaluated potential anti-angiogenic effects of several compounds including small-molecule kinase inhibitors, such as sunitinib (pan-kinase inhibitor), tofacitinib (JAK-inhibitor), NIKi (NF-κB-inducing kinase inhibitor), and the integrin-targeting peptide fluciclatide, using a scratch assay and 3D spheroid-based models of angiogenesis.

View Article and Find Full Text PDF

GRP78/BiP, a stress-induced protein and autoantigen in rheumatoid arthritis (RA), exhibits different expressions in various biological fluids and tissues, including blood, synovial fluid (SF), and synovium, all of which are pertinent to the disease activity and progression of RA; however, there is a scarcity of data linking both intracellular and extracellular GRP78/Bip to disease activity and progression of RA. This study was undertaken to investigate the differential expression of GRP78/Bip in blood, SF, and synovium, and to determine their association with disease activity and progression of RA. Patients with RA, osteoarthritis (OA), and traumatic meniscal injury (TMI) without radiographic OA were consecutively recruited for the study.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!